2 ms·
Best part is the Oxford devices are _actually affordable_. Illumina has had such a stranglehold on the market - devices start at around 35k and go up into “this
by dhash 6y ago
Best part is the Oxford devices are _actually affordable_. Illumina has had such a stranglehold on the market - devices start at around 35k and go up into “this is a house now” territory. Meanwhile the Flongle [0] is $99 and the main Oxford device can be had for $1k.
[0] https://store.nanoporetech.com/us/flowcells/flongle-flow-cell.html https://store.nanoporetech.com/us/flowcells/flongle-flow-cel...
- bsder 6y ago> Illumina has had such a stranglehold on the market - devices start at around 35k and go up into “this is a house now” territory. You cannot effectively sell this kind of device under $25K--support costs simply eat your profit margin. This is a constant across industries. You either have a $250 thneed (and you ignore your customers) or a $25K thneed (and you have shitty customer support) or a $250K thneed (and you have decent customer support).
- zmmmmm 6y agoDepends what you mean by affordable - low barrier to entry, yes. But bases / $ is still orders of magnitude below where needed to displace Illumina for sequencing of large genomes (eg: human).